Bora Pharmaceuticals Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bora Pharmaceuticals Co Ltd with three other
companies in this sector in TAIWAN :
Sinphar Pharmaceutical C O., Ltd.
sales of 2.39 billion Taiwanese Dollars [US$85.12 million]
of which 66%
Chi Sheng Pharma & Biotech Co Ltd
(979.36 million Taiwanese Dollars [US$34.90 million]
of which 100%
was Single Segment), and
Nang Kuang Pharmaceutical Co Ltd
(1.75 billion Taiwanese Dollars [US$62.54 million]
of which 92%
was Western medicine).
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Bora Pharmaceuticals Co Ltd totalled
1.19 billion Taiwanese Dollars .
an increase of 229.7%
from the 362.11 million Taiwanese Dollars in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 2.56 billion Taiwanese Dollars , which is
than through the first two quarters of 2020.
There appears to be at least some degree of seasonality in the sales at Bora Pharmaceuticals Co Ltd: during 5 of the previous 6
years, sales were highest during the fourth quarter.
The exception to this was during 2018, when the
second quarter was the best quarter, accounting for
29% of sales (during that same year, the
fourth quarter accounted for 28% of sales).
Bora Pharmaceuticals Co Ltd reported sales of 1.80 billion Taiwanese Dollars (US$64.14 million)
December of 2020.
increase of 17.7%
versus 2019, when the company's sales were 1.53 billion Taiwanese Dollars .
Sales at Bora Pharmaceuticals Co Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 657%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
2,142.9% in 2020, from
1.79 million Taiwanese Dollars to 40.19 million Taiwanese Dollars .